Karl Winckel

5PUBLICATIONS
8CO-AUTHORS
Toxicology (incl. clinical toxicology)Professional ethicsCardiology (incl. cardiovascular diseases)Medical biochemistry - inorganic elements and compoundsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 02, 2025
Evaluating the Effectiveness of Risk Categories for Prioritising Patients for Best Possible Medication History Completion at a Quaternary Hospital.

Marissa Ryan, Jane Dunsdon, Karl Winckel

|Jul 22, 2024
Evaluation of an interactive education workshop on hospital pharmacists' ethical reasoning: an observational study.

Nallini McCleery, Adam La Caze, Karl Winckel

|Apr 01, 2024
Evaluation of the Quality and Safety of Venous Thromboembolism Prophylaxis Among Gastroenterology Inpatients at a Tertiary Hospital in Australia.

Nameer van Oosterom, Keshia R De Guzman, Karl Winckel

|Feb 05, 2020
Comment On: "Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study".

Nameer van Oosterom, Karl Winckel, Michael Barras

|Apr 05, 2019
Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity.

Nameer van Oosterom, Karl Winckel, Michael Barras

Pageof 1

Frequent Collaborators

2 joint publications

Nameer van Oosterom

2 joint publications

Michael Barras

1 joint publications

Keshia R De Guzman

1 joint publications

Nallini McCleery